A unique telephone-counseling intervention not only improved the quality of life for cervical cancer survivors but also altered associated stress-related effects on their immune systems, a UC Irvine study has found.
Along with reporting psychological and social benefits, the women in the study were found to have improved anti-tumor immune responses. The findings point to the importance of a “mind-body” connection for surviving cancer with a higher quality of life.
“Cervical cancer survivors frequently experience profound and long-lasting quality of life issues, yet they often do not avail themselves of cancer support resources and are in desperate need of psychosocial interventions that work for them,” said Lari Wenzel, associate professor of medicine and public health at UC Irvine and co-lead author of the study. “This telephone-counseling strategy provided broad access to help women manage the stressors associated with cancer and its treatment.”
The researchers studied 50 women from September 2004 to December 2005 who had completed primary cervical cancer treatment at least six months before starting the counseling program. The standardized telephone counseling focused on stress and emotion management and health and wellness issues.
In addition to the patient-reported psychological and social effects of the study, the researchers looked at what can be called the “mind-body” connection, which explores how behavioral interventions can affect other parts of the body.
Blood tests on the women who completed the counseling program showed a shift in the immune system, specifically with a class of T-helper immune cells, toward the type of immune response that seeks out and destroys tumor cells. Dr. Edward Nelson, UCI oncologist, tumor immunologist and co-lead author on the study, said the shift in these biomarkers was associated with the quality of life improvements that resulted from the telephone-counseling sessions helping participants address and relieve stress.
Previous studies have shown that chronic stress can hamper the immune system’s ability to destroy tumor cells, Nelson said.
“Our counseling program is showing that stress reduction can positively influence cancer survivorship psychologically, socially and, potentially, medically.
“There is a great deal of public interest in the mind-body connection, and this study moves the field a step closer to identifying how psychosocial and complementary interventions might improve health outcomes.”
Nelson and Wenzel both stress that although their data identifies changes in health that should put the immune system in a better position to fight cancer, demonstration of any improvement in survival will require much larger studies with much longer follow-up. The researchers have received a $3.1 million National Institutes of Health grant to study this in a larger population throughout Southern California.
The study appears in the April edition of Clinical Cancer Research. Wenzel is a researcher with the Center for Health Policy Research at UCI. Nelson is a physician/scientist with its Center for Immunology. Both are members of the Chao Family Comprehensive Cancer Center.
Source: University of California - Irvine
Related stories:
New study sheds light on how intracellular pathogens trigger the immune system
(PhysOrg.com) -- Disease-causing microbes like the food-borne bacterium Listeria monocytogenes specialize in invading and replicating inside their animal hosts' own cells, making them particularly tricky to defeat. Now, a new study led by biologists at the University of California, Berkeley, has identified a molecular alarm system in which the intracellular pathogen sends out signals that kick the immune response into gear.
Researchers hack final part of the immune system code
A group of researchers from the University of Copenhagen and the Biocentre at the Technical University of Denmark have managed to decipher the final part of the immune system’s key codes.
Salmonella toll tops 1,000; peppers now eyed
(AP) -- More than 1,000 people now are confirmed ill from salmonella initially linked to raw tomatoes, a grim milestone Wednesday that makes this the worst foodborne outbreak in at least a decade. Adding to the confusion, the government is warning certain people to avoid types of hot peppers, too.
Hepatitis C virus may need enzyme's help to cause liver disease
A key enzyme may explain how hepatitis C infection causes fatty liver – a buildup of excess fat in the liver, which can lead to life-threatening diseases such as cirrhosis and liver cancer, report University of Pittsburgh Graduate School of Public Health and School of Medicine researchers.
Researchers identify potential new drug candidates to combat 'bird flu'
As the specter of a worldwide outbreak of avian or "bird flu" lingers, health officials recognize that new drugs are desperately needed since some strains of the virus already have developed resistance to the current roster of anti-flu remedies.
Cancer 'cure' in mice to be tested in humans
Scientists at Wake Forest University Baptist Medical Center are about to embark on a human trial to test whether a new cancer treatment will be as effective at eradicating cancer in humans as it has proven to be in mice.
Predicting the risk of a common fungal infection after stem cell transplantation
In silico genetic analysis in mice has led to the discovery of a gene affecting susceptibility to a severe fungal infection in transplant recipients. In a study published June 20th in the open-access journal
PLoS Genetics, investigators from Duke University Medical Center, the National Institute of Environmental Health Sciences, Roche Palo Alto, the Fred Hutchinson Cancer Research Center, and the National Jewish Medical and Research Center found that genetic variation within the plasminogen gene in mice and men affects susceptibility to a severe and life-threatening fungal infection.
Same drug, different results: MUHC researcher on the path to personalized medicine
Minor genetic differences between individuals change the effect of a common medication, study shows
Medicine has moved a little bit closer to the era of tailor-made treatments, based on the unique genetic profiles of individual patients, according to recent research conducted by Dr Rima Rozen of the Research Institute of the McGill University Health Centre (RI MUHC) at the Montreal Children's Hospital and McGill University. Her study, published June 18 in the journal Pharmacogenetics and Genomics, shows how minor genetic differences between individuals alter the way a common drug affects the body.